Company will showcase new assay at the upcoming San Antonio Breast Cancer Symposium. MINNEAPOLIS, Dec. 10, 2024 /PRNewswire/ -- Bio-Techne ...
News
- BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY - PR Newswire
- Tempus Announces Four Abstracts Accepted for Presentation at the 2024 San Antonio ...
... San Antonio Breast Cancer Symposium, which convenes from December 10-13, in San Antonio, Texas. "Presenting our latest research at the San Antonio ...
- Zetagen Therapeutics Shares In-vivo Dose Optimization Data of ZetaMAST™ (Zeta-MBC ...
Zetagen will attend the upcoming San Antonio Breast Cancer Symposium (SABCS) and the JP Morgan Healthcare Conference. Post to LinkedIn · Share on ...
- Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of ...
These data will be presented in a poster at the 2024 San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas. Preliminary results from ...
- BostonGene Unveils Transformative Breast Cancer Research at 2024 San Antonio ... - Business Wire
... San Antonio Breast Cancer Symposium (SABCS), to take place December 10 - 13, 2024, at the Henry B. Gonzalez Convention Center in San Antonio, Texas.